(R)-1-Ethyl-3-methyl-piperazine dihydrochloride, 95.0%, 100mg

2-Cyano-3-(3-chlorophenylethyl)pyridine, 97%, 10g

(R)-7-(3-aminopyrrolidin-1-yl)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide, 98%, 100mg

Scintillation vials, 5 ml, 2000 Piece(s)

1,3-Dimethyl-1H-pyrazole-4-sulfonamide, 98.0%, 5g

(S)-2-Acetamido-3-hydroxypropanoic acid, 95.0%, 1g

5-Fluoro-2-methylbenzyl bromide, 95.0%, 10g

3-Chloro-2-(2,4-dichlorophenoxy)-5-(trifluoromethyl)pyridine, 95.0%, 5g

2-(4,6-Dimethyl-pyrimidin-2-ylsulfanyl)-propionic acid, 95.0%, 5g

Methyl 3-methylisoxazole-5-carboxylate, 95.0%, 250mg

1,5-Naphthalenedisulfonic acid tetrahydrate, 98.0%, 500g

2-Cyclobutoxypyridine-3-carboxylic acid, 1g

6-Bromo-2-pyridinecarboxaldehyde>98.0%(GC)1g